发明公开
EP1611088A2 HYDROXAMATES AS THERAPEUTIC AGENTS 有权
羟肟酸盐治疗药物

HYDROXAMATES AS THERAPEUTIC AGENTS
摘要:
The present invention is directed to certain hydroxamate derivatives that are useful in the treatment of hepatitis C. These compounds are also inhibitors of histone deacetylase and are therefore useful in the treatment of diseases associated with histone deacetylase activity. Pharmaceutical compositions and processes for preparing these compounds are also disclosed.
公开/授权文献
信息查询
0/0